Clinical trial • Phase III • Oncology

Clinical trial in Non-Hodgkin lymphoma | B-cell non-Hodgkin lymphoma

Phase III trial for Non-Hodgkin lymphoma | B-cell non-Hodgkin lymphoma. 78 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Non-Hodgkin lymphoma | B-cell non-Hodgkin lymphoma
Trial Stage
Phase III

Key dates

Initial CTIS Submission Date
03-07-2024
First CTIS Authorization Date
24-07-2024

Trial design

Phase III trial across 13 sites in Spain, Italy.

Target Sample Size
78

Recruitment

Planned Sample Size
78
Recruitment Window Months
48

Geography

Total Number Of Sites
13
Total Number Of Participants
52

Spain

Earliest CTIS Part Ii Submission Date
18-07-2024
Latest Decision Or Authorization Date
12-11-2025
Processing Time Days
482
Number Of Sites
7
Number Of Participants
32

Sites

Site Name
Hospital Universitari Vall D Hebron
Department Name
Oncology
Contact Person Name
Pau Abrisqueta
Contact Person Email
pabrisqueta@vhebron.net
Site Name
Clinica Universidad De Navarra
Department Name
Oncology
Contact Person Name
Carlos Grande García
Contact Person Email
cgrandeg@unav.es
Site Name
Institut Catala D'oncologia
Department Name
Oncology
Contact Person Name
Eva María González-Barca
Contact Person Email
e.gonzalez@iconcologia.net
Site Name
Hospital Universitario Y Politecnico La Fe
Department Name
Oncology
Contact Person Name
Isidro Jarque Ramos
Contact Person Email
jarque_isi@gva.es
Site Name
Hospital Universitario De Salamanca
Department Name
Oncology
Contact Person Name
Alejandro Martín
Site Name
Hospital General Universitario Gregorio Maranon
Department Name
Oncology
Contact Person Name
Mariana Bastos Oreiro
Site Name
Hospital Universitari Vall D Hebron (duplicate entry if present)
Department Name
Oncology
Contact Person Name
Pau Abrisqueta
Contact Person Email
pabrisqueta@vhebron.net

Italy

Earliest CTIS Part Ii Submission Date
18-07-2024
Latest Decision Or Authorization Date
10-11-2025
Processing Time Days
480
Number Of Sites
6
Number Of Participants
20

Sites

Site Name
Ospedale San Raffaele S.r.l.
Department Name
Lymphoma Unit - Department of Onco-Hematology
Contact Person Name
Andres Jose Maria Ferreri
Contact Person Email
ferrari.andres@hsr.it
Site Name
Azienda Ospedaliero Universitaria Pisana
Department Name
Hematology Department
Contact Person Name
Sara Galimberti
Contact Person Email
sara.galimberti@unipi.it
Site Name
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Department Name
Hematology Unit
Contact Person Name
Pierluigi Zinzani
Contact Person Email
pierluigi.zinzani@unibo.it
Site Name
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Department Name
Hematology Department
Contact Person Name
Alessandra Tucci
Site Name
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
Department Name
Hematology Department
Contact Person Name
Gerardo Musuraca
Contact Person Email
gerardo.musuraca@irst.emr.it
Site Name
Ospedale San Raffaele S.r.l. (duplicate entry if present)
Department Name
Lymphoma Unit - Department of Onco-Hematology
Contact Person Name
Andres Jose Maria Ferreri
Contact Person Email
ferrari.andres@hsr.it

Sponsor

Primary sponsor

Full Name
F. Hoffmann-La Roche AG
Organisation Type
Pharmaceutical company
Country Of Registered Address
Switzerland

Investigational products

Combination Treatment
Yes

Related trials

Other published trials that may interest you.